BioNTech

News

Pfizer claims new $3.2bn COVID jab deal with US government

Pfizer and BioNTech have signed a new $3.2 billion supply contract with the US government for COVID-19 vaccines, covering 105 million doses that may include Omicron-targeted shots.

News

US panel backs Omicron-targeting vaccines for booster campai...

Future booster campaigns against COVID-19 should include vaccines with a component targeting the Omicron variant of SARS-CoV-2, according to the FDA's Vaccines and Related Biological Produc

News

FDA advisors back COVID jabs for very young children

The FDA's vaccines advisors have voted in favour of extending the use of mRNA-based COVID-19 vaccine from Moderna and Pfizer/BioNTech to include children from the ages of six months.

Digital

Pfizer: Pharma needs a business strategy for a digital world

The unprecedented rate of digital acceleration seen in the first two years of COVID-19 has set in train an age of digital transformation.

News

Doctor in white rubber protective gloves putting adhesive bandage on young man's arm after scratch on skin or injection of vaccine. First aid. Medical, pharmacy and healthcare concept. Closeup.

COV-BOOST trial data show value of fourth dose

Administering a fourth dose of an mRNA COVID-19 vaccine provides a stronger level of protection than a third dose, particularly in the over-70s, according to the latest readout from the UK

News